about
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingDrug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patientsGenome-wide and fine-resolution association analysis of malaria in West AfricaReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportGenomic analysis of local variation and recent evolution in Plasmodium vivax.Elusive Plasmodium Species Complete the Human Malaria Genome SetVarB: a variation browsing and analysis tool for variants derived from next-generation sequencing dataSnoopCGH: software for visualizing comparative genomic hybridization dataFurther evidence supporting a role for gs signal transduction in severe malaria pathogenesisPopulation genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assayPlasmodium malariae and P. ovale genomes provide insights into malaria parasite evolutionContrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and EliminationDihydrofolate-Reductase Mutations in Plasmodium knowlesi Appear Unrelated to Selective Drug Pressure from Putative Human-To-Human Transmission in Sabah, MalaysiaA new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genesGenetic diversity and population structure of Plasmodium vivax in Central ChinaDissecting malaria biology and epidemiology using population genetics and genomics.Characterization of Within-Host Plasmodium falciparum Diversity Using Next-Generation Sequence DataEffective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencingVivaxGEN: An open access platform for comparative analysis of short tandem repeat genotyping data in Plasmodium vivax populationsGenome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in KenyaAn effective method to purify Plasmodium falciparum DNA directly from clinical blood samples for whole genome high-throughput sequencing.Validating discovered Cis-acting regulatory genetic variants: application of an allele specific expression approach to HapMap populationsLack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populationsA Bayesian approach using covariance of single nucleotide polymorphism data to detect differences in linkage disequilibrium patterns between groups of individuals.Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infectionsComparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialAllelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility.A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility.Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia.Variation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern EthiopiaUsing CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samplesExpression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years.G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational StudyGenetic determinants of anti-malarial acquired immunity in a large multi-centre studyWhere chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan.Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, IndonesiaMolecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
P50
Q20901697-D416F316-79CB-43C7-907B-B153B76FC9ABQ21091002-B2C5D62F-9660-4FEB-A914-39643C30A6EAQ24632119-957E9C69-0A8E-4C8E-94C2-623C39120391Q27024922-044E6A27-00A3-4319-9CEC-B7567203D1B4Q27149930-471357D9-F3A9-4F8D-847B-4C21E9563750Q28030927-058AFAC9-3DC7-4BEF-9FD2-890D2A318DE1Q28030976-C5C0CD1E-A498-472F-B84D-FDC722B2D770Q28031390-C0C1D4E8-6D81-4ACF-9C6A-C92B72F6ABBFQ28473594-ACFC28C8-9788-4E71-AC79-45E961376F8FQ28478444-26810F92-98DB-44C2-A76B-E4056C378226Q28529647-71DBA7B3-BEA1-4FAA-8000-1AD52ECD6FE4Q28547081-8E39CCA1-1B7B-4FFB-B126-FB60E386AD5CQ28550436-67DE4639-55A7-4FD4-B966-2A43E27C0F9AQ28585693-B0856E63-D9AA-47A9-AFCF-0BBBD6F7FA44Q28655779-66CCAEE2-0199-4DA1-99E8-5666CFEE359CQ30241593-898FD9A2-17B8-4E41-9F66-CB26D1DFB651Q30303389-1F60EF1B-8280-4581-A1DF-3E4C70069B37Q30303389-52BF0B20-98CF-4DE9-846A-EEBF5686BEC4Q30459215-814ADF41-C71C-4CC8-89BD-C5689FC03299Q30491283-B6AE6F4B-5D45-4D41-B45E-63D249E86724Q31076495-108F8393-227A-47C6-8BF4-68E95C951B83Q31077064-6958C14C-8E88-4497-A9A4-765D5EA85BA1Q33396680-EEA35B78-218F-40A2-8BE7-65063071CF95Q33399957-5D601160-4CA5-4C4F-ABA1-4D259A665804Q33606661-48CF8668-7CE0-4A8D-8BD6-1E882B66EE4FQ33674933-07CDB2A5-2545-4B4A-8DE0-A701D09D299AQ33693625-42C147A5-0D5A-4DC6-A80B-F0A4A856C140Q34326937-3F1FDC42-AAAA-4D83-BCA1-409F6CEFB439Q34352459-384978EC-1A05-47B8-82D5-D4147F095D09Q35072841-4ED77430-3745-4A82-B415-680BED867532Q35807931-6A868865-B3BC-4E2C-96DC-AD5E684C8E65Q35808996-C2B22B4B-7A5A-4503-9E2C-FBB0053DFD6CQ35829555-9578F3E5-A848-4AC5-BB1D-BAF2354A9105Q35962523-0447A0B6-1DB8-4D2F-9CA4-862E98905402Q36003357-5AB3192A-EA93-40EE-9252-2527D6BC4CEDQ36004135-712F5B6B-ACD6-4F89-A90F-1D4EC9556CF7Q36017165-FB7643BA-2335-4FCB-BA1B-E35D769B7A01Q36176399-CAF454E9-3594-4D01-A5D4-4BFA9B323541Q36187618-53190C82-63DC-4AC3-AC92-793A9AB23800Q36232661-A4C14561-A2FD-4B43-8834-AA7919F0060C
P50
description
geneticist and epidemiologist
@en
wetenschapper
@nl
name
Sarah Auburn
@ast
Sarah Auburn
@en
Sarah Auburn
@es
Sarah Auburn
@fr
Sarah Auburn
@nl
Sarah Auburn
@sl
type
label
Sarah Auburn
@ast
Sarah Auburn
@en
Sarah Auburn
@es
Sarah Auburn
@fr
Sarah Auburn
@nl
Sarah Auburn
@sl
prefLabel
Sarah Auburn
@ast
Sarah Auburn
@en
Sarah Auburn
@es
Sarah Auburn
@fr
Sarah Auburn
@nl
Sarah Auburn
@sl
P1053
N-2266-2013
P106
P21
P31
P3829
P496
0000-0002-4638-536X
P569
2000-01-01T00:00:00Z